A recent report on the global vaccines market notes: âTen years ago, the vaccine market sat at $5.7 billion dollarsâŚnow, that market has soared to $27 billion.â So in just ten years the vaccine market has risen by more than $20 billion. This is astonishing. Is all this vaccination really necessary and beneficial to individuals, or is there some very lucrative over-vaccination going on, with the sanction of governments and the medical/scientific establishment?
There are forces working very hard to set up a massive international vaccine market in developed and developing countries. Relationships between the vaccine industry and organisations such as the World Health Organisation (WHO), US Centers for Disease Control and Prevention (CDC), US National Institutes of Health (NIH), the GAVI Alliance, and the Bill & Melinda Gates Foundation etc need to be scrutinised.
Children are the major target for the vaccine industryâs growth, as indicated by ever-increasing national vaccination schedules. In recent times adults are also being urged to have repeated vaccinations, for example flu vaccination every year.
There appears to be little consultation with the general public about additions to vaccination schedules, and there are concerns about potential conflicts of interest of government health advisors in this area. This issue has been polarised between âproâ and âantiâ vaccination factions, with any questioning of the vaccination status quo being regarded as taboo.
It is now taken as a given that âvaccination is goodâ, âvaccination is safeâ, âyou canât have too many vaccinesâ. Paul Offit, Chief of the Division of Infectious Diseases and the Director of the Vaccine Education Center at the Childrenâs Hospital of Philadelphia, is famous for his flippant remark that a babyâs immune system could handle as many as 10,000 vaccines, and upping the ante by saying it was probably âcloser to 100,000â.
It seems that an entirely cavalier attitude has developed towards vaccination and, as a result, new vaccines continue to be added to vaccination schedules with an alarming lack of transparency of the process.
With vaccine manufacturers sizing up the potential for lucrative global vaccine markets, and scientists lining up for vaccine royalties, there are strong vested interests to consider, plus questions about the long-term efficacy of some vaccines, inadequately researched possible adverse reactions to vaccination, and the, in effect, limited liability of international vaccine manufacturers.
Citizens must be allowed to have a rational debate on this important subject to ensure public confidence in vaccination practice. All vaccination recommendations must be transparently evidence-based.
For more analysis of the vaccine industry see Over-vaccination.netâs web pages on:
- pertussis / whooping cough â how does increasing the numbers of âboostersâ of the current vaccine protect against the new strain?;
- questions for the Australian Technical Advisory Group on Immunisation (ATAGI) and the Australian Academy of Science re âThe Science of Immunisation: Questions and Answersâ; and